Dupasquier Sébastien, Delmarcelle Anne-Sophie, Marbaix Etienne, Cosyns Jean-Pierre, Courtoy Pierre J, Pierreux Christophe E
CELL Unit, de Duve Institute and Université catholique de Louvain UCL-ICP, Avenue Hippocrate 75, 1200 Brussels, Belgium.
BMC Mol Biol. 2014 May 16;15:9. doi: 10.1186/1471-2199-15-9.
YBX3/ZONAB/CSDA is an epithelial-specific transcription factor acting in the density-based switch between proliferation and differentiation. Our laboratory reported overexpression of YBX3 in clear cell renal cell arcinoma (ccRCC), as part of a wide study of YBX3 regulation in vitro and in vivo. The preliminary data was limited to 5 cases, of which only 3 could be compared to paired normal tissue, and beta-Actin was used as sole reference to normalize gene expression. We thus decided to re-evaluate YBX3 expression by real-time-PCR in a larger panel of ccRCC samples, and their paired healthy tissue, with special attention on experimental biases such as inter-individual variations, primer specificity, and reference gene for normalization.
Gene expression was measured by RT-qPCR in 16 ccRCC samples, each compared to corresponding healthy tissue to minimize inter-individual variations. Eight potential housekeeping genes were evaluated for expression level and stability among the 16-paired samples. Among tested housekeeping genes, PPIA and RPS13, especially in combination, proved best suitable to normalize gene expression in ccRCC tissues as compared to classical reference genes such as beta-Actin, GAPDH, 18S or B2M. Using this pair as reference, YBX3 expression level among a collection of 16 ccRCC tumors was not significantly increased as compared to normal adjacent tissues. However, stratification according to Fuhrman grade disclosed higher YBX3 expression levels in low-grade tumors and lower in high-grade tumors. Immunoperoxidase confirmed homogeneous nuclear staining for YBX3 in low-grade but revealed nuclear heterogeneity in high-grade tumors.
This paper underlines that special attention to reference gene products in the design of real-time PCR analysis of tumoral tissue is crucial to avoid misleading conclusions. Furthermore, we found that global YBX3/ZONAB/CSDA mRNA expression level may be considered within a "signature" of RCC grading.
YBX3/ZONAB/CSDA是一种上皮特异性转录因子,在基于密度的增殖与分化转换中发挥作用。我们实验室报道了YBX3在透明细胞肾细胞癌(ccRCC)中的过表达,这是对YBX3在体外和体内调控的广泛研究的一部分。初步数据仅限于5例,其中只有3例可与配对的正常组织进行比较,并且仅使用β-肌动蛋白作为标准化基因表达的唯一参照。因此,我们决定通过实时定量PCR在更大的ccRCC样本组及其配对的健康组织中重新评估YBX3的表达,特别关注个体间差异、引物特异性和标准化参照基因等实验偏差。
通过RT-qPCR在16例ccRCC样本中测量基因表达,每个样本都与相应的健康组织进行比较,以尽量减少个体间差异。在16对样本中评估了8个潜在的管家基因的表达水平和稳定性。在测试的管家基因中,与经典参照基因如β-肌动蛋白、甘油醛-3-磷酸脱氢酶、18S或β2微球蛋白相比,肽基脯氨酰异构酶A(PPIA)和核糖体蛋白S13(RPS13),尤其是两者结合,被证明最适合标准化ccRCC组织中的基因表达。以这一对基因作为参照,与相邻正常组织相比,16例ccRCC肿瘤样本中YBX3的表达水平没有显著增加。然而,根据Fuhrman分级进行分层显示,低级别肿瘤中YBX3表达水平较高,高级别肿瘤中较低。免疫过氧化物酶法证实低级别肿瘤中YBX3呈均匀的核染色,但在高级别肿瘤中显示核异质性。
本文强调在肿瘤组织实时PCR分析设计中特别关注参照基因产物对于避免误导性结论至关重要。此外,我们发现YBX3/ZONAB/CSDA的整体mRNA表达水平可在RCC分级的“特征”范围内予以考虑。